Mark A. Velleca - 07 Feb 2022 Form 4 Insider Report for G1 Therapeutics, Inc.

Role
Director
Signature
/s/ James Stillman Hanson, attorney-in-fact
Issuer symbol
N/A
Transactions as of
07 Feb 2022
Net transactions value
+$5,850
Form type
4
Filing time
08 Feb 2022, 15:05:58 UTC
Previous filing
10 Nov 2021
Next filing
18 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Options Exercise $5,850 +15,000 +15% $0.3900* 116,000 07 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Options (Right to Buy) Options Exercise $0 -15,000 -8% $0.000000 172,286 07 Feb 2022 Common Stock 15,000 $0.3900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares underlying this option have vested.